Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2005 Jul 20;2005(3):CD005310.
doi: 10.1002/14651858.CD005310.pub2.

Methylxanthines for prolonged non-specific cough in children

A B Chang  1 , R A Halstead, H L Petsky
Affiliations

Methylxanthines for prolonged non-specific cough in children

A B Chang et al. Cochrane Database Syst Rev. .

Abstract

Background: Non-specific cough is defined as non-productive cough in the absence of identifiable respiratory disease or known aetiology. It is commonly seen in paediatric practice. These children are treated with a variety of therapies including a variety of asthma medications. Methylxanthines, the main medication used for paediatric asthma for many decades in Western countries, is still widely used in non-Western countries. Also, methylxanthines have other pharmacological properties and their bronchodilator effect is only modest.

Objectives: To evaluate the efficacy of methylxanthines in treating children with non-specific cough.

Search strategy: The Cochrane Register of Controlled Trials (CENTRAL), the Cochrane Airways Group Specialised Register Collaboration and Cochrane Airways Group, MEDLINE and EMBASE databases were searched by the Cochrane Airways Group. The latest searches were performed in Jan 2005.

Selection criteria: All randomised controlled trials comparing methylxanthines with a placebo medication in treating children with non-specific cough.

Data collection and analysis: Results of searches were reviewed against pre-determined criteria for inclusion. No eligible trials were identified and thus no data were available for analysis. Four small non-randomised controlled trials were reported.

Main results: No randomised controlled trials that examined the efficacy of methylxanthines in the management of prolonged non-specific cough in children were found. In the non randomised trials above, a significant effect was seen within 2-14 days of therapy.

Authors' conclusions: There is currently an absence of reliable evidence to support the routine use of methylxanthines for symptomatic control of non-specific cough in children. If methylxanthines were to be trialled in children with prolonged non-specific cough, cohort data (thus limited) suggest a clinical response (subjective cough severity) would be seen within 2-5 days (and certainly within 14 days) of therapy. However methylxanthine use has to be balanced against the well known risk of toxicity and its low therapeutic range in children. Further research examining the efficacy of this intervention is needed.

PubMed Disclaimer

Conflict of interest statement

None known.

Update of

  • doi: 10.1002/14651858.CD005310

References

References to studies excluded from this review

Bose 1987 {published data only}
    1. Bose B, Cater JI, Clark RA. A once daily theophylline preparation in prevention of nocturnal symptoms in childhood asthma. European Journal of Pediatrics 1987;146(5):524‐7. - PubMed
Cazzola 1993 {published data only}
    1. Cazzola M, Matera MG, Liccardi G, Prisco F, D'Amato G, Rossi F. Theophylline in the inhibition of angiotensin‐converting enzyme inhibitor‐induced cough. Respiration 1993;60(4):212‐5. - PubMed
Chyrek 1988 {published data only}
    1. Chyrek‐Borowska S, Szymanski W, Niklinska B, Obrzut D, Michalska I. Clinical evaluation of the effectiveness of aminophylline in treating bronchial asthma and spastic bronchitis [Ocena kliniczna skutecznosci aminofiliny w terapii astmy oskrzelowej i spastycznego niezytu oskrzeli]. Polski Tygodnik Lekarski 1988;43:1377‐9. - PubMed
Cloutier 1981 {published data only}
    1. Cloutier MM, Loughlin GM. Chronic cough in children: a manifestation of airway hyperreactivity. Pediatrics 1981;67:6‐12. - PubMed
Hannaway 1982 {published data only}
    1. Hannaway PJ, Hopper GDK. Cough variant asthma in children. JAMA 1982;247:206‐8. - PubMed
Konig 1981 {published data only}
    1. Konig P. Hidden asthma in children. American Journal of Diseases of Children 1981;135:1053‐5. - PubMed
Perez 1994 {published data only}
    1. Perez NJ, Serna PC. Functional and clinical evaluation of the bronchodilator effect of acebrophylline in obstructive pulmonary disease in children [Valoracion funcional y clinica del efecfto broncodilatador de la acebrofilina en la patologia pulmonar obstructiva del nino]. Investigacion Medica Internacional 1994;21(2):67‐71.
Rachelefsky 1980 {published data only}
    1. Rachelefsky GS, Katz RM, Mickey MR Jr, Siegel SC. Metaproterenol and theophylline in asthmatic children. Annals of Allergy 1980;45(4):207‐12. - PubMed
Selby 1997 {published data only}
    1. Selby C, Engleman HM, Fitzpatrick MF, Sime PM, Mackay TW, Douglas NJ. Inhaled salmeterol or oral theophylline in nocturnal asthma?. American Journal of Respiratory & Critical Care Medicine 1997;155(1):104‐8. - PubMed
Usmani 2005 {published data only}
    1. Usmani OS, Belvisi MG, Patel HJ, Crispino N, Birrell MA, Korbonits M, et al. Theobromine inhibits sensory nerve activation and cough. FASEB Journal 2005;19(2):231‐3. - PubMed
Yahav 1982 {published data only}
    1. Yahav Y, Katznelson D, Benzaray S. Persistent cough ‐ a forme‐fruste of asthma. European Journal of Respiratory Diseases 1982;63:43‐6. - PubMed

Additional references

Bath 2004
    1. Bath PMW, Bath‐Hextall FJ. Pentoxifylline, propentofylline and pentifylline for acute ischaemic stroke. Cochrane Database of Systematic Reviews 2004, Issue 3. [Art. No.: CD000162.pub2. DOI: 10.1002/14651858.CD000162.pub2] - PubMed
Britt 2002
    1. Britt H, Miller GC, Knox S, Charles J, Valenti L, Henderson J, et al. Bettering the evaluation and care of health ‐ a study of general practice activity. Australian Institue of Health and Welfare, 2002. AIHW Cat. No. GEP‐10.
Cates 2003 [Computer program]
    1. Cates C. Visual Rx. Online NNT Calculator.. http://www.nntonline.net/: Cates C, 2003.
Cazzola 1993
    1. Cazzola M, Matera MG, Liccardi G, Prisco F, D'Amato G, Rossi F. Theophylline in the inhibition of angiotensin‐converting enzyme inhibitor‐induced cough. Respiration 1993;60(4):212‐5. - PubMed
Chang 1999
    1. Chang AB. State of the art: cough, cough receptors, and asthma in children. Pediatric Pulmonology 1999;28:59‐70. - PubMed
Chang 2001
    1. Chang AB, Asher MI. A review of cough in children. Journal of Asthma 2001;38(4):299‐309. - PubMed
Cherry 2003
    1. Cherry DK, Burt CW, Woodwell DA. National ambulatory medical care survey: 2001 summary. Advance Data 2003;337:1‐44. - PubMed
Cornford 1993
    1. Cornford CS, Morgan M, Ridsdale L. Why do mothers consult when their children cough?. Family Practice 1993;10(2):193‐6. - PubMed
Elbourne 2002
    1. Elbourne DR, Altman DG, Higgins JPT, Curtin F, Worthington HV, Vail A. Meta‐analyses involving cross‐over trials: methodological issues. International Journal of Epidemiology 2002;31(1):140‐9. - PubMed
McKenzie 1994
    1. McKenzie S. Cough ‐ but is it asthma?. Archives of Disease in Childhood 1994;70:1‐2. - PMC - PubMed
Millar 2004
    1. Millar D, Schmidt B. Controversies surrounding xanthine therapy. Seminars in Neonatology 2004;9(3):239‐44. - PubMed
Rabe 1998
    1. Rabe KF, Dent G. Theophylline and airway inflammation. Clinical and Experimental Allergy 1998;28(Suppl 3):35‐41. - PubMed
Ram 2002
    1. Ram FSF, Jones PW, Castro AA, Brito JJR, Atallah AN, Lacasse Y, et al. Oral theophylline for chronic obstructive pulmonary disease. Cochrane Database of Systematic Reviews 2002, Issue 3. [DOI: 10.1002/14651858.CD003902] - DOI - PMC - PubMed
Skoner 2002
    1. Skoner DP. Balancing safety and efficacy in pediatric asthma management. Pediatrics 2002;109(2 Suppl):381‐92. - PubMed
Stein 1996
    1. Stein MA, Krasowski M, Leventhal BL, Phillips W, Bender BG. Behavioral and cognitive effects of methylxanthines. A meta‐analysis of theophylline and caffeine. Archives of Pediatrics & Adolescent Medicine 1996;150(3):284‐8. - PubMed
Vassallo 1998
    1. Vassallo R, Lipsky JJ. Theophylline: recent advances in the understanding of its mode of action and uses in clinical practice. Mayo Clinic Proceedings 1998;73(4):346‐54. - PubMed

Publication types